Themajorresponse from researchers performing GWAShas been to continuallyincreasesample sizes, giving thempower to revealvariants with ever-smaller effectsizes.
Blue Pillar has deployed its network platform on 50 sites encompassing over 1, 050 endpoints, representing over 150 megawatts of capacity in major demand response markets.
The long timelines for drug development stem from a large number of factors, but one of the key reasons is that the FDA, largely in response to major drug problems with drugs like Rezulin and the Cox-2 inhibitors, has required larger and longer trials.